Cargando…
Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations
BACKGROUND: To achieve the elimination of hepatitis B and C, there is an urgent need to develop alternative strategies to increase the access of diagnosis, particularly among key populations such as people living with human immunodeficiency virus (HIV), individuals with coagulopathies and chronic ki...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080549/ https://www.ncbi.nlm.nih.gov/pubmed/33959230 http://dx.doi.org/10.4254/wjh.v13.i4.504 |
_version_ | 1783685452125962240 |
---|---|
author | Flores, Geane Lopes Barbosa, Jakeline Ribeiro Cruz, Helena Medina Miguel, Juliana Custódio Potsch, Denise Vigo Pilotto, José Henrique Lima, Danielle Malta Baima Colares, Jeová Keny Brandão-Mello, Carlos Eduardo Pires, Marcia Maria Amendola da Mota, Jurema Corrêa Bastos, Francisco I Lewis-Ximenez, Lia Laura Villar, Livia Melo |
author_facet | Flores, Geane Lopes Barbosa, Jakeline Ribeiro Cruz, Helena Medina Miguel, Juliana Custódio Potsch, Denise Vigo Pilotto, José Henrique Lima, Danielle Malta Baima Colares, Jeová Keny Brandão-Mello, Carlos Eduardo Pires, Marcia Maria Amendola da Mota, Jurema Corrêa Bastos, Francisco I Lewis-Ximenez, Lia Laura Villar, Livia Melo |
author_sort | Flores, Geane Lopes |
collection | PubMed |
description | BACKGROUND: To achieve the elimination of hepatitis B and C, there is an urgent need to develop alternative strategies to increase the access of diagnosis, particularly among key populations such as people living with human immunodeficiency virus (HIV), individuals with coagulopathies and chronic kidney disease (CKD) patients. AIM: To evaluate the use of dried blood spot (DBS) in the detection of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers. METHODS: A total of 430 individuals comprised of people living with HIV, coagulopathies and CKD provided paired serum and DBS samples. HBsAg, anti-HBc and anti-HCV were tested in those samples using a commercial electrochemiluminescence. Demographic and selected behavioral variables were evaluated to assess possible association with HBV and HCV positivity. RESULTS: Using DBS, HBsAg prevalence varied from 3.9% to 22.1%, anti-HBc rates varied from 25.5% to 45.6% and anti-HCV positivity ranged from 15.9% to 41.2% in key populations. Specificities of HBV and HCV tests using DBS varied from 88.9% to 100%. The HBsAg assay demonstrated the best performance in CKD and coagulopathy individuals and the anti-HCV test had a sensitivity and specificity of 100% in people living with HIV. Accuracy of HBV and HCV detection in DBS varied from 90.2% to 100%. In the CKD group, HBsAg positivity was associated with infrequent use of condoms, and anti-HBc positivity was associated with sharing nail cutters/razors/toothbrushes. Anti-HCV reactivity was positively associated with a history of transplantation and length of time using hemodialysis in both specimens. In people living with HIV, only the male gender was associated with anti-HBc positivity in serum and DBS. CONCLUSION: DBS with electrochemiluminescence are useful tools for the diagnosis and prevalence studies of hepatitis B and C among key populations and may increase the opportunity to foster prevention and treatment. |
format | Online Article Text |
id | pubmed-8080549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-80805492021-05-05 Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations Flores, Geane Lopes Barbosa, Jakeline Ribeiro Cruz, Helena Medina Miguel, Juliana Custódio Potsch, Denise Vigo Pilotto, José Henrique Lima, Danielle Malta Baima Colares, Jeová Keny Brandão-Mello, Carlos Eduardo Pires, Marcia Maria Amendola da Mota, Jurema Corrêa Bastos, Francisco I Lewis-Ximenez, Lia Laura Villar, Livia Melo World J Hepatol Observational Study BACKGROUND: To achieve the elimination of hepatitis B and C, there is an urgent need to develop alternative strategies to increase the access of diagnosis, particularly among key populations such as people living with human immunodeficiency virus (HIV), individuals with coagulopathies and chronic kidney disease (CKD) patients. AIM: To evaluate the use of dried blood spot (DBS) in the detection of hepatitis B virus (HBV) and hepatitis C virus (HCV) markers. METHODS: A total of 430 individuals comprised of people living with HIV, coagulopathies and CKD provided paired serum and DBS samples. HBsAg, anti-HBc and anti-HCV were tested in those samples using a commercial electrochemiluminescence. Demographic and selected behavioral variables were evaluated to assess possible association with HBV and HCV positivity. RESULTS: Using DBS, HBsAg prevalence varied from 3.9% to 22.1%, anti-HBc rates varied from 25.5% to 45.6% and anti-HCV positivity ranged from 15.9% to 41.2% in key populations. Specificities of HBV and HCV tests using DBS varied from 88.9% to 100%. The HBsAg assay demonstrated the best performance in CKD and coagulopathy individuals and the anti-HCV test had a sensitivity and specificity of 100% in people living with HIV. Accuracy of HBV and HCV detection in DBS varied from 90.2% to 100%. In the CKD group, HBsAg positivity was associated with infrequent use of condoms, and anti-HBc positivity was associated with sharing nail cutters/razors/toothbrushes. Anti-HCV reactivity was positively associated with a history of transplantation and length of time using hemodialysis in both specimens. In people living with HIV, only the male gender was associated with anti-HBc positivity in serum and DBS. CONCLUSION: DBS with electrochemiluminescence are useful tools for the diagnosis and prevalence studies of hepatitis B and C among key populations and may increase the opportunity to foster prevention and treatment. Baishideng Publishing Group Inc 2021-04-27 2021-04-27 /pmc/articles/PMC8080549/ /pubmed/33959230 http://dx.doi.org/10.4254/wjh.v13.i4.504 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Observational Study Flores, Geane Lopes Barbosa, Jakeline Ribeiro Cruz, Helena Medina Miguel, Juliana Custódio Potsch, Denise Vigo Pilotto, José Henrique Lima, Danielle Malta Baima Colares, Jeová Keny Brandão-Mello, Carlos Eduardo Pires, Marcia Maria Amendola da Mota, Jurema Corrêa Bastos, Francisco I Lewis-Ximenez, Lia Laura Villar, Livia Melo Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations |
title | Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations |
title_full | Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations |
title_fullStr | Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations |
title_full_unstemmed | Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations |
title_short | Dried blood spot sampling as an alternative for the improvement of hepatitis B and C diagnosis in key populations |
title_sort | dried blood spot sampling as an alternative for the improvement of hepatitis b and c diagnosis in key populations |
topic | Observational Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080549/ https://www.ncbi.nlm.nih.gov/pubmed/33959230 http://dx.doi.org/10.4254/wjh.v13.i4.504 |
work_keys_str_mv | AT floresgeanelopes driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT barbosajakelineribeiro driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT cruzhelenamedina driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT migueljulianacustodio driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT potschdenisevigo driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT pilottojosehenrique driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT limadaniellemalta driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT baimacolaresjeovakeny driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT brandaomellocarloseduardo driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT piresmarciamariaamendola driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT damotajuremacorrea driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT bastosfranciscoi driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT lewisximenezlialaura driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations AT villarliviamelo driedbloodspotsamplingasanalternativefortheimprovementofhepatitisbandcdiagnosisinkeypopulations |